<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02696343</url>
  </required_header>
  <id_info>
    <org_study_id>UNL IRB Project ID #15446</org_study_id>
    <nct_id>NCT02696343</nct_id>
  </id_info>
  <brief_title>Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants</brief_title>
  <official_title>Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska Lincoln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tufts Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CIRI/CHI Institute for Research and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>California Institute for Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Tech University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nebraska Lincoln</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two innovative approaches, pulsatile orocutaneous entrainment of non-nutritive suck via
      orosensory entrainment (NTrainer) device technology and serial salivary gene expression
      analyses, will be merged to examine the relation between gene expression, oral somatosensory
      stimulation, feeding behavior, and neurodevelopmental outcomes at 18 months corrected age
      (CA) on 180 extremely preterm infants [EPIs] (24 0/7-26 6/7 GA and 27 0/7 - 28 6/7 GA)
      enrolled at three neonatal intensive care units: Catholic Health Initiative (CHI) Health St.
      Elizabeth (Lincoln, NE), Tufts Medical Center (Boston, MA), and Santa Clara Valley Medical
      Center (San Jose, CA). EPIs will be randomized to a blind pacifier (SHAM) or PULSED NTrainer
      treatment groups, and stratified by GA, sex, and bronchopulmonary dysplasia status (BPD vs
      non-BPD). We hypothesize that the combination of the NTrainer® intervention for improved oral
      feeding skills, along with objective salivary gene expression data to monitor response to
      treatment and feeding development, will result in a novel, objective, and personalized
      approach to neonatal oral feeding and reduce the duration of time to attain oral feeds while
      improving feeding, growth and neurodevelopmental outcomes at 18 months' CA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Salivary gene expression</measure>
    <time_frame>Quantify gene expression probability from salivary samples beginning at 30 wks post-menstrual age, and repeated sampling every 3 days thereafter during the infant's stay in neonatal intensive care unit (NICU) for an average of 14 samples, up to 60 days.</time_frame>
    <description>Plexin A1 (PLXNA1), Plexin A3 (PLXNA3), Neuropeptide Y2 receptor (NPY2R), Wingless-type integration site family (WNT3), Adenosine-monophosphate-activated protein kinase (AMPK), and Nephronophthisis 4 (NPHP4) gene expression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>National Institute Child Human Development (NICHD) Neonatal Research Network feed-growth questionnaire</measure>
    <time_frame>18 months corrected age (CA)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bayley III Developmental Scales</measure>
    <time_frame>18-24 months corrected age (CA)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-nutritive suck (NNS) bursts/minute</measure>
    <time_frame>Beginning at 30 wks post-menstrual age, and repeated biomechanical sampling of suck bursts/min (2 min sample) every 3 days thereafter during the infant's stay in the NICU for an average of 12 NNS samples, and up to 60 days.</time_frame>
    <description>NNS Bursts/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-to-transition to full oral feed</measure>
    <time_frame>Time expressed in days for an infant to attain full oral feed (100% PO), assessed on a daily basis beginning at 30 weeks post-menstrual age (PMA) through hospital stay in the NICU, for an average of 56 %PO measures sampled over 8 weeks.</time_frame>
    <description>Time to Full Oral Feed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-nutritive suck cycles/min</measure>
    <time_frame>Beginning at 30 wks post-menstrual age, and repeated biomechanical sampling of suck compressions/min (2-min sample) every 3 days thereafter during the infant's stay in the NICU for an average of 12 NNS samples, and up to 60 days.</time_frame>
    <description>NNS Cycles/min</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Infant, Extremely Low Birth Weight</condition>
  <condition>Feeding Behavior</condition>
  <arm_group>
    <arm_group_label>EPI experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Preterm infants randomized to receive the PULSED orocutaneous somatosensory stimulation from the NTrainer during tube feedings.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EPI control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Preterm infants randomized to receive the Sham (blind pacifier) during tube feedings.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NTrainer</intervention_name>
    <description>pulsed orocutaneous stimulation paired with tube feedings</description>
    <arm_group_label>EPI experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SHAM blind pacifier</intervention_name>
    <description>regular green Soothie pacifier paired with tube feedings</description>
    <arm_group_label>EPI control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Extremely preterm infants (EPIs) born between 24 0/7 and 28 6/7 weeks' GA, as
             determined by obstetric ultrasound at &lt; 15 weeks or last menstrual period

          -  Enroll EPIs once they have a corrected PCA of ≥ 29 weeks

          -  Approximately equal numbers of males and females, no exclusion based on race/ethnicity

        Exclusion Criteria:

          -  Chromosomal and congenital anomalies including craniofacial malformation, nervous
             system anomalies, cyanotic congenital heart disease, gastroschisis, omphalocele,
             diaphragmatic hernia and/or other major gastrointestinal anomalies

          -  Congenital infection

          -  No documented GA

          -  Severe IUGR (3%)

          -  Head circumference &lt; 10th or &gt; 90th percentile

          -  Intracranial hemorrhage grades III and IV, seizures

          -  Meningitis

          -  Neurological examination showing abnormal tone or movements of all extremities for PCA

          -  History of necrotizing enterocolitis (stage II and III)

          -  Culture-positive sepsis at the time of study enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven M Barlow, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jill L Maron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven M Barlow, PhD</last_name>
    <phone>4024723956</phone>
    <email>steven.barlow@unl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Santa Clara Valley Medical Center</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95128-2604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongli Song, MD, PhD</last_name>
      <phone>408-885-5420</phone>
      <email>dongli.song@hhs.sccgov.org</email>
    </contact>
    <investigator>
      <last_name>Dongli Song, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111-1526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill L Maron, MD</last_name>
      <phone>617-636-0766</phone>
      <email>jmaron@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Jill L Maron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI St. Elizabeth's Medical Center</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68512</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>February 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2016</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>somatosensory stimulation</keyword>
  <keyword>orocutaneous</keyword>
  <keyword>gene expression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

